The pandemic of coronavirus disease (COVID)-2019 has been affected many people all around the world Patients with mental disorders are not as safe as others;also, they might be more vulnerable in such situations These patients take various medications, which can lead to numerous drug-drug interactions with experimental drugs uses against COVID-19 According to the potential critical interactions, we reviewed the reputable databases to find the interactions between main categories of psychiatric medications (e g , antidepressants, anti-psychotics, sedative/hypnotics, and mood stabilizers) when used in concomitant with COVID-19 experimental agents (e g , hydroxychloroquine, lopinavir/ritonavir, atazanavir, and chloroquine) We hope the list provided in this review helps the clinical care staff in treating patients with mental illness infected with severe acute respiratory syndrome coronavirus 2 during the COVID-19 pandemic
Drug-drug interaction between psychiatric medications and experimental treatments forcoronavirusdisease-19:A mini-review